CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis.
Cyclin-dependent kinase 5 (CDK5) is a cytoplasmic serine/ threonine kinase. Knockdown of CDK5 enhances paclitaxel sensitivity in human ovarian cancer cells. This study explores the mechanisms by which CDK5 regulates paclitaxel sensitivity in human ovarian cancers. Multiple ovarian cancer cell lines...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0131833&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849726790668386304 |
|---|---|
| author | Shu Zhang Zhen Lu Weiqun Mao Ahmed A Ahmed Hailing Yang Jinhua Zhou Nicholas Jennings Cristian Rodriguez-Aguayo Gabriel Lopez-Berestein Roberto Miranda Wei Qiao Veera Baladandayuthapani Zongfang Li Anil K Sood Jinsong Liu Xiao-Feng Le Robert C Bast |
| author_facet | Shu Zhang Zhen Lu Weiqun Mao Ahmed A Ahmed Hailing Yang Jinhua Zhou Nicholas Jennings Cristian Rodriguez-Aguayo Gabriel Lopez-Berestein Roberto Miranda Wei Qiao Veera Baladandayuthapani Zongfang Li Anil K Sood Jinsong Liu Xiao-Feng Le Robert C Bast |
| author_sort | Shu Zhang |
| collection | DOAJ |
| description | Cyclin-dependent kinase 5 (CDK5) is a cytoplasmic serine/ threonine kinase. Knockdown of CDK5 enhances paclitaxel sensitivity in human ovarian cancer cells. This study explores the mechanisms by which CDK5 regulates paclitaxel sensitivity in human ovarian cancers. Multiple ovarian cancer cell lines and xenografts were treated with CDK5 small interfering RNA (siRNA) with or without paclitaxel to examine the effect on cancer cell viability, cell cycle arrest and tumor growth. CDK5 protein was measured by immunohistochemical staining of an ovarian cancer tissue microarray to correlate CDK5 expression with overall patient survival. Knockdown of CDK5 with siRNAs inhibits activation of AKT which significantly correlates with decreased cell growth and enhanced paclitaxel sensitivity in ovarian cancer cell lines. In addition, CDK5 knockdown alone and in combination with paclitaxel induced G1 cell cycle arrest and caspase 3 dependent apoptotic cell death associated with post-translational upregulation and nuclear translocation of TP53 and p27(Kip1) as well as TP53-dependent transcriptional induction of p21(Cip1) in wild type TP53 cancer cells. Treatment of HEYA8 and A2780 wild type TP53 xenografts in nu/nu mice with CDK5 siRNA and paclitaxel produced significantly greater growth inhibition than either treatment alone. Increased expression of CDK5 in human ovarian cancers correlates inversely with overall survival. CDK5 modulates paclitaxel sensitivity by regulating AKT activation, the cell cycle and caspase-dependent apoptosis. CDK5 inhibition can potentiate paclitaxel activity in human ovarian cancer cells. |
| format | Article |
| id | doaj-art-cbbd8a5e117f459093a006bc7bf4fb97 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-cbbd8a5e117f459093a006bc7bf4fb972025-08-20T03:10:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013183310.1371/journal.pone.0131833CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis.Shu ZhangZhen LuWeiqun MaoAhmed A AhmedHailing YangJinhua ZhouNicholas JenningsCristian Rodriguez-AguayoGabriel Lopez-BeresteinRoberto MirandaWei QiaoVeera BaladandayuthapaniZongfang LiAnil K SoodJinsong LiuXiao-Feng LeRobert C BastCyclin-dependent kinase 5 (CDK5) is a cytoplasmic serine/ threonine kinase. Knockdown of CDK5 enhances paclitaxel sensitivity in human ovarian cancer cells. This study explores the mechanisms by which CDK5 regulates paclitaxel sensitivity in human ovarian cancers. Multiple ovarian cancer cell lines and xenografts were treated with CDK5 small interfering RNA (siRNA) with or without paclitaxel to examine the effect on cancer cell viability, cell cycle arrest and tumor growth. CDK5 protein was measured by immunohistochemical staining of an ovarian cancer tissue microarray to correlate CDK5 expression with overall patient survival. Knockdown of CDK5 with siRNAs inhibits activation of AKT which significantly correlates with decreased cell growth and enhanced paclitaxel sensitivity in ovarian cancer cell lines. In addition, CDK5 knockdown alone and in combination with paclitaxel induced G1 cell cycle arrest and caspase 3 dependent apoptotic cell death associated with post-translational upregulation and nuclear translocation of TP53 and p27(Kip1) as well as TP53-dependent transcriptional induction of p21(Cip1) in wild type TP53 cancer cells. Treatment of HEYA8 and A2780 wild type TP53 xenografts in nu/nu mice with CDK5 siRNA and paclitaxel produced significantly greater growth inhibition than either treatment alone. Increased expression of CDK5 in human ovarian cancers correlates inversely with overall survival. CDK5 modulates paclitaxel sensitivity by regulating AKT activation, the cell cycle and caspase-dependent apoptosis. CDK5 inhibition can potentiate paclitaxel activity in human ovarian cancer cells.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0131833&type=printable |
| spellingShingle | Shu Zhang Zhen Lu Weiqun Mao Ahmed A Ahmed Hailing Yang Jinhua Zhou Nicholas Jennings Cristian Rodriguez-Aguayo Gabriel Lopez-Berestein Roberto Miranda Wei Qiao Veera Baladandayuthapani Zongfang Li Anil K Sood Jinsong Liu Xiao-Feng Le Robert C Bast CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. PLoS ONE |
| title | CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. |
| title_full | CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. |
| title_fullStr | CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. |
| title_full_unstemmed | CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. |
| title_short | CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. |
| title_sort | cdk5 regulates paclitaxel sensitivity in ovarian cancer cells by modulating akt activation p21cip1 and p27kip1 mediated g1 cell cycle arrest and apoptosis |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0131833&type=printable |
| work_keys_str_mv | AT shuzhang cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT zhenlu cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT weiqunmao cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT ahmedaahmed cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT hailingyang cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT jinhuazhou cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT nicholasjennings cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT cristianrodriguezaguayo cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT gabriellopezberestein cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT robertomiranda cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT weiqiao cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT veerabaladandayuthapani cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT zongfangli cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT anilksood cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT jinsongliu cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT xiaofengle cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis AT robertcbast cdk5regulatespaclitaxelsensitivityinovariancancercellsbymodulatingaktactivationp21cip1andp27kip1mediatedg1cellcyclearrestandapoptosis |